<html><body><pre>[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2820 Engrossed in House (EH)]

114th CONGRESS
  1st Session
                                H. R. 2820

_______________________________________________________________________

                                 AN ACT


 
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and 
                          for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

     This Act may be cited as the ``Stem Cell Therapeutic and Research 
Reauthorization Act of 2015''.

SEC. 2. AMENDMENTS TO THE STEM CELL THERAPEUTIC AND RESEARCH ACT OF 
              2005.

    (a) Cord Blood Inventory.--Section 2 of the Stem Cell Therapeutic 
and Research Act of 2005 (42 U.S.C. 274k note) is amended in subsection 
(h)--
            (1) in paragraph (1)--
                    (A) by striking ``$23,000,000 for each of fiscal 
                years 2011 through 2014 and''; and
                    (B) by inserting before the period at the end the 
                following: ``and $23,000,000 for each of fiscal years 
                2016 through 2020''; and
            (2) in paragraph (2), by striking ``2011 through 2015'' and 
        inserting ``2015 through 2020''.
    (b) National Program.--Section 379B of the Public Health Service 
Act (42 U.S.C. 274m) is amended by striking ``2011 through 2014'' and 
inserting ``2016 through 2020''.

            Passed the House of Representatives September 8, 2015.

            Attest:

                                                                 Clerk.
114th CONGRESS

  1st Session

                               H. R. 2820

_______________________________________________________________________

                                 AN ACT

To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and 
                          for other purposes.
</pre></body></html>
